AIRR - ANZCA Institutional Research Repository
Skip navigation
Please use this identifier to cite or link to this item: http://hdl.handle.net/11055/913
Full metadata record
DC FieldValueLanguage
dc.contributor.authorShakespeare Timothy Jamesen_US
dc.date.accessioned2019-11-27T03:17:14Z-
dc.date.available2019-11-27T03:17:14Z-
dc.date.issued1999-11-
dc.identifier.urihttp://hdl.handle.net/11055/913-
dc.description.abstractLeukaemia Inhibitory Factor (LIF) is a polyfunctional cytokine, which has been shown to enhance nerve regeneration. The mechanism of action of LIF is unknown; however, LIF has been shown to induce superinduction of Nitric Oxide Synthase II (NOS-II) in smooth muscle cells. We investigated whether inhibition of NOS-II alters LIF action on nerve regeneration in vivo. The sciatic nerve of rats was transected at mid-thigh level and repaired by suturing the stumps into each end of a 14mm silicone tube, leaving a 10mm sealed chamber. The tube was filled with 10mg of LIF in Phosphate Buffered Saline (PBS) or PBS alone. Half the rats were injected daily with 3mg/kg body-weight, intraperitoneal, of the specific NOS-II inhibitor aminoethylisothiourea (AET). At 2 weeks, 4 weeks, and 12 weeks post transection, the rats were sacrificed. At 4 weeks the sciatic nerves were fixed in glutaraldehyde, transverse sections were taken 6mm proximal to the proximal end of the tube, at the proximal, middle and distal ends of the tube; and at 6mm distal to the tube. LIF enhanced myelineated axon regeneration, across the chamber compared to PBS. In AET treated groups, axon regeneration was largely absent. At 12 weeks muscle contraction studies were performed and muscle weights compared between the groups. There was no statistically significant difference between the groups; however, the addition of AET for 4 weeks appeared to produce a trend toward lower muscle weights and weaker contractile tetanic forces. This demonstrates that NOS-II plays an important role in axonal regeneration across the chamber at the 4 week time point in our entubation repair model, and may also have a detrimental effect at 12 weeks. Furthermore, this data suggests that LIF may act, at least in part, via NOS-II to enhance nerve regeneration.en_US
dc.subjectratsen_US
dc.subjectLIF protein, humanen_US
dc.subjectLeukemia Inhibitory Factoren_US
dc.subjectNitric Oxide Synthase Type IIen_US
dc.subjectsciatic nerveen_US
dc.subjectnerve regenerationen_US
dc.subjectmuscle contractionen_US
dc.subjectMyocytes, smooth muscleen_US
dc.subjectaxonsen_US
dc.titleThe inhibition of Leukaemia Inhibitory Factor Enhanced nerve regeneration by the action of the specific Nitric Oxide Synthase II inhibitor Aminoethylisothioureaen_US
dc.typeThesis and Dissertationen_US
dc.type.contentTexten_US
dc.description.affiliatesUniversity of Melbourne, Department of Surgery, St. Vincent's Hospital, Melbourne, Australiaen_US
dc.contributor.anzcaShakespeare, TJen_US
dc.description.heldatAustralian and New Zealand College of Anaesthetists (Library); Barcode: 3002636-
Appears in Collections:Scholarly and Clinical

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.